STOCK TITAN

Insmed officer William Lewis plans $1.26M share sale

The notice also reports seven earlier sales by Lewis, including a 25,564-share sale on May 18, 2026.

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Insmed Inc (INSM) officer William Lewis reported plans to sell 10,699 common shares, with an aggregate market value of $1,256,029 and an approximate sale date of July 9, 2026. The shares are listed as acquired from the issuer through stock plan activity on July 9, 2026. A Rule 10b5-1 plan adoption or instruction date is listed as September 4, 2025.

Lewis’s listed prior sales ran from April 16 through June 25, 2026, and ranged from 6,515 to 25,564 shares, with gross proceeds per transaction ranging from $612,576 to $2,718,106.

Planned sale 10,699 shares Approximate sale date July 9, 2026
Aggregate market value $1,256,029 Shares listed for sale
Stock-plan shares acquired 10,699 shares Acquired from the issuer on July 9, 2026
Prior sale 25,564 shares May 18, 2026
Gross proceeds $2,718,106 Prior sale on May 18, 2026
Rule 10b5-1 plan adoption or instruction date September 4, 2025 Date listed in the plan disclosure
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Stock Plan Activity financial
"Nature of Acquisition Transaction"
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INSM shares does William Lewis plan to sell?

William Lewis plans to sell 10,699 common shares, with an aggregate market value of $1,256,029 and an approximate sale date of July 9, 2026.

What was William Lewis’s largest recent INSM sale?

Lewis sold 25,564 common shares on May 18, 2026, for gross proceeds of $2,718,106.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading